Showing results (1671-1680 of 1,701) with videos related to

Sort By:
Pageof 171
BMC Infectious Diseases|October 8, 2025
Association of overweight with treatment outcomes in pulmonary tuberculosisKyung Hoon Kim, Hyung Woo Kim, Eung Gu Lee, et al.
British Journal of Cancer|September 23, 2020
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neckHye Ryun Kim, Han Na Kang, Mi Ran Yun, et al.
Cancer Research and Treatment|December 14, 2021
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking GroupShinkyo Yoon, Miso Kim, Yong Sang Hong, et al.
Genome Medicine|March 1, 2014
Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokersJin Woo Ahn, Han Sang Kim, Jung-Ki Yoon, et al.
Journal of Breast Cancer|March 3, 2024
Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority TrialJi-Jung Jung, Jong-Ho Cheun, Soo-Yeon Kim, et al.
Molecular Cancer|March 29, 2023
Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic disseminationHyunbin D Huh, Yujin Sub, Jongwook Oh, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 4, 2020
Differential clinical impact of chronic total occlusion revascularization based on left ventricular systolic functionHyungdon Kook, Jeong Hoon Yang, Jae Young Cho, et al.
Lancet (London, England)|December 15, 2022
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South KoreaJeongha Mok, Myungsun Lee, Deog Kyeom Kim, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2021
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary TuberculosisJu Sang Kim, Yong-Hyun Kim, Sang Haak Lee, et al.
Nature Communications|November 1, 2022
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signalingLee Shaashua, Aviad Ben-Shmuel, Meirav Pevsner-Fischer, et al.
Pageof 171